ADVERTISEMENT
For Indian Drugmakers, This Is The Best Performing Business During Pandemic
The pharma firms’ segments that make raw materials for drugs led their outperformance in Q1.
13 Aug 2020, 09:24 AM IST
While Indian pharmaceutical firms saw their business grow in the quarter ended June aided by increased demand amid the Covid-19 outbreak, the bulk drug segment was the outperformer.The active pharmaceutical ingredient business, or raw materials that go into making medicines, benefited from the curbs on imports from China after a border scuffle left around 20 Indian soldiers and an unknown number of Chinese military personnel dead in ...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT